Rocket Lab's Split Personality: Record Launch Cadence Meets a Halved Share Price

Rocket Lab's shares fall 59% from May peak even as Electron launches hit record pace and backlog grows to $2.36B, with Neutron debut eyed for 2026.

There is a peculiar disconnect at the heart of Rocket Lab's current market narrative. The company just notched its 94th Electron launch — a StriX satellite for Japanese Earth-observation firm Synspective riding to a 575-kilometer low-Earth orbit from Launch Complex 1 in Mahia, New Zealand — marking the 15th mission of the year. By that measure alone, Electron remains the most frequently launched small rocket on the planet. Yet the equity tells a different story entirely.

Shares closed Wednesday at €54.50, roughly 59% below the May peak of €133.80, and sit 18% under the 50-day moving average of €66.16. The 30-day slide alone amounts to 12%, matching the year-to-date decline. With annualized volatility running at 71%, this is one of the jumpier names in the New Space universe — a stock that has been cut nearly in half while its operational engine hums along.

The Backlog Keeps Growing

The operational picture, for what it's worth, has rarely looked stronger. Rocket Lab's record order book stood at $2.36 billion at the end of the second quarter — a 137% expansion over the course of a single year — and management has already flagged more than $1 billion in fresh awards during the third quarter. The company guides to revenue between $250 million and $265 million for the current period.

That momentum extends well beyond the launch manifest. Viasat tapped Rocket Lab in August to supply a Lightning GEO satellite bus for a mini-GEO mission under the Protected Tactical SATCOM-Global program. The US Space Force added the company to its NITE-STAR framework with a potential value of up to $981 million, and doled out another $12 million in task orders through the Space Data Network Consortium. The takeaway: Rocket Lab is quietly embedding itself into American space-defense infrastructure in ways that distinguish it from pure-play satellite suppliers.

Neutron's Clock Is Ticking

The market's impatience, though, centers on what comes next. Development of the larger Neutron rocket has cleared meaningful hurdles — the "Hungry Hippo" fairing has completed its full test campaign, core subsystems are integrated, and hundreds of ignition tests on the Archimedes engine are in the books. Management still targets a first Neutron launch by the end of 2026, a deadline that carries outsized weight for the investment thesis since it represents Rocket Lab's entry ticket into the medium-lift class.

That timeline is precisely where analysts diverge. Berenberg initiated coverage Tuesday with a Buy rating and an $83 price target, calling Rocket Lab the only publicly traded pure-play in the space sector with a fully integrated value chain from launch vehicles to differentiated satellite constellations. Bank of America, by contrast, trimmed its target from $115 to $110 on Monday — while keeping its Buy rating intact. The stock slipped 2.2% on that adjustment.

Insider Sales, Cathie Wood Buys

The recent insider selling has added another layer of noise. President Marvin Bradford Clevenger disposed of roughly 15,000 shares on August 24 in a tax-motivated, non-discretionary transaction tied to restricted stock unit vesting, at a weighted average price of $69.63. Chief Operating Officer Frank Klein and General Counsel Arjun Kampani also trimmed positions late August through pre-arranged Rule 10b5-1 plans — Klein selling between $66.25 and $67.54, Kampani between $66.50 and $67.16.

These are textbook mechanics of equity compensation, not red flags. But timing matters to a skittish market, and observers are reading more into the pattern than the transactions themselves may warrant.

On the other side of the ledger sits Cathie Wood's ARK Invest, which added more than 700,000 shares to its position through late August and early September — a counter-cyclical bet made even as Neutron delay concerns and insider sales weighed on sentiment. Institutional investors, in other words, are drawing sharply different conclusions from the same news flow.

The Iridium Marathon

The longer structural play runs through the multibillion-dollar acquisition of Iridium Communications. The antitrust waiting period lapsed in mid-August, and Rocket Lab has since filed a registration statement with US regulators on behalf of Iridium shareholders. Completion is targeted for mid-2027, subject to Iridium stockholder approval and remaining regulatory clearances — a horizon long enough to inject persistent uncertainty into an already volatile equity.

Whether the gap between operational delivery and share price performance narrows may ultimately hinge on Neutron's debut. Until then, Rocket Lab offers a study in contrasts: a company firing rockets at record frequency while its stock trades as though the mission has already failed.